Science also stresses that lenacapavir becoming a key drug to accelerate HIV prevention largely depends on access to the drug. "The price, which has not yet been set, will determine who can afford ...

As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir – a promising new injectable drug that prevents HIV infection. The award also recognizes related work ...

The 2024 breakthrough of the year, according to the journal Science, was with the drug lenacapavir, an antiretroviral medicine that performed very well in scientific trials. Dr. Robert Hopkins Jr ...

But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking clinical trial results for a drug called lenacapavir showed it to be ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...

The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science magazine's "Breakthrough of the Year" jury announced on Thursday.

The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 annually in the U.S. and is administered in twice-yearly doses. While the drug appears to be effective ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection... Can we eliminate the HIV epidemic? It's a ...

More from the Fact-Check Team: How we pick and research claims | Email newsletter | Facebook page The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 ...